Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 275 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 12/25/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 11/05/21
End: 12/20/21
Due: 12/20/22
Phase: N/A
Priority: Normal
Start: 05/01/15
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 04/14/18
End: 08/10/19
Due: 08/10/20
Phase: N/A
Priority: Normal
Start: 02/20/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/22/20
End: 06/10/22
Due: 06/10/23
Phase: N/A
Priority: Normal
Start: 06/21/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 08/15/23
End: 02/27/24
Due: 02/27/25
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 04/25/19
Due: 04/25/20
Phase: N/A
Priority: Normal
Start: 05/02/24
End: 03/31/29
Due: 03/31/30
Phase: N/A
Priority: Normal
Start: 10/16/20
End: 05/16/23
Due: 05/16/24
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 12/31/17
Due: 12/31/18
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Phase: N/A
Priority: Normal
Start: 10/15/23
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 02/26/16
End: 03/13/18
Due: 03/13/19
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 06/06/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 03/15/23
End: 10/30/24
Due: 10/30/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 01/05/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/10/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 08/15/20
End: 06/15/22
Due: 06/15/23